The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 03, 2023

Filed:

Dec. 13, 2018
Applicant:

Momenta Pharmaceuticals, Inc., Cambridge, MA (US);

Inventors:

Leona E. Ling, Winchester, MA (US);

Darrell Nix, Colebrook, NH (US);

Nicholas A. Cilfone, Cambridge, MA (US);

Assignee:

MOMENTA PHARMACEUTICALS, INC., Cambridge, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 37/02 (2006.01);
U.S. Cl.
CPC ...
C07K 16/283 (2013.01); A61P 37/02 (2018.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01);
Abstract

The present invention features antibodies that bind to human neonatal Fc receptor (FcRn). These anti-FcRn antibodies are useful, e.g., to promote clearance of autoantibodies in a subject, to suppress antigen presentation in a subject, to block an immune response, e.g., block an immune complex-based activation of the immune response in a subject, and to treat immunological diseases (e.g., autoimmune diseases) in a subject. These anti-FcRn antibodies are also useful, e.g., to decrease pathogenic antibody transport across the placenta of a pregnant subject, to increase pathogenic antibody catabolism in a pregnant subject, and to treat an antibody-mediated enhancement of viral disease in a fetus or a neonate.


Find Patent Forward Citations

Loading…